Milestone Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Regulatory and Corporate Update

MONTREAL and CHARLOTTE, N.C., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today reported financial results for the third quarter ending September 30, 2025, and ...
The Globe and Mail

Milestone Pharmaceuticals to Present New Analysis from Investigational Etripamil Nasal Spray Clinical Trials for PSVT at the American Heart Association Scientific Sessions 2025

Analysis of data from 622 unique enrolled patients across multiple trials showed consistent efficacy of etripamil across multiple study phases, types of trial design, and geographic regions, with ...

Jefferies Lifts Milestone Pharmaceuticals (MIST) Price Targets on Product Sales Prospects

Milestone Pharmaceuticals (NASDAQ:MIST) is one of the Canadian penny stocks to buy right now. On November 13, analysts at Jefferies reiterated a Hold rating on Milestone Pharmaceuticals (NASDAQ: MIST) ...
Hosted on MSN

First budget meeting with new Lackawanna County Interim Commissioner Brenda Sacco

This was the first meeting since the board reorganized on Friday, and accusations are now flying among the county commissioners. Trump’s shutdown win just landed Republicans with a huge political ...